S2Medical AB engages in research and development in biotechnology. It develops and sells wound healing products for the entire wound healing process focusing on burns and chronic wounds. It offers wound debridement, blood stilling, skin grafting, tissue substitutes, bandage, and antimicrobial products. The company was founded by Petter Sivlér and Mårten Skog on June 13, 2013 and is headquartered in Linköping, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company